| Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems BJ Gardiner, AJ Stewardson, IJ Abbott, AY Peleg Australian prescriber 42 (1), 14, 2019 | 177 | 2019 |
| Clinical and microbiological characteristics of Eggerthella lenta bacteremia BJ Gardiner, AY Tai, D Kotsanas, MJ Francis, SA Roberts, SA Ballard, ... Journal of Clinical Microbiology 53 (2), 626-635, 2015 | 142 | 2015 |
| Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis? BJ Gardiner, AA Mahony, AG Ellis, N Lawrentschuk, DM Bolton, ... Clinical Infectious Diseases 58 (4), e101-e105, 2014 | 137 | 2014 |
| Faecal microbiota transplantation for severe Clostridium difficile infection in the intensive care unit JA Trubiano, B Gardiner, JC Kwong, P Ward, AG Testro, PGP Charles European journal of gastroenterology & hepatology 25 (2), 255-257, 2013 | 81 | 2013 |
| Fosfomycin for treatment of prostatitis: new tricks for old dogs ML Grayson, N Macesic, J Trevillyan, AG Ellis, PT Zeglinski, NH Hewitt, ... Clinical Infectious Diseases 61 (7), 1141-1143, 2015 | 72 | 2015 |
| Absolute lymphocyte count: a predictor of recurrent cytomegalovirus disease in solid organ transplant recipients BJ Gardiner, NE Nierenberg, JK Chow, R Ruthazer, DM Kent, ... Clinical Infectious Diseases 67 (9), 1395-1402, 2018 | 67 | 2018 |
| Role of secondary prophylaxis with valganciclovir in the prevention of recurrent cytomegalovirus disease in solid organ transplant recipients BJ Gardiner, JK Chow, LL Price, NE Nierenberg, DM Kent, DR Snydman Clinical Infectious Diseases 65 (12), 2000-2007, 2017 | 53 | 2017 |
| Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis NJ Rhodes, BJ Gardiner, MN Neely, ML Grayson, AG Ellis, ... Journal of antimicrobial chemotherapy 70 (7), 2068-2073, 2015 | 49 | 2015 |
| Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial JH McMahon, JSY Lau, A Coldham, J Roney, M Hagenauer, S Price, ... EClinicalMedicine 54, 2022 | 33 | 2022 |
| Inducible resistance to clindamycin in Staphylococcus aureus: validation of Vitek-2 against CLSI D-test BJ Gardiner, ML Grayson, GM Wood Pathology-Journal of the RCPA 45 (2), 181-184, 2013 | 25 | 2013 |
| Reactivation of latent cytomegalovirus infection in patients with rheumatologic disease: a case–control study BJ Gardiner, EM Haas, RC Bailey, JK Chow, DR Snydman Rheumatology international 39, 1229-1240, 2019 | 24 | 2019 |
| Eggerthella lenta bacteremia complicated by spondylodiscitis, psoas abscess, and meningitis BJ Gardiner, TM Korman, RK Junckerstorff Journal of Clinical Microbiology 52 (4), 1278-1280, 2014 | 20 | 2014 |
| Evaluation of Quantiferon®‐Monitor as a biomarker of immunosuppression and predictor of infection in lung transplant recipients BJ Gardiner, SJ Lee, Y Cristiano, BJ Levvey, LC Sullivan, GI Snell, ... Transplant Infectious Disease 23 (3), e13550, 2021 | 18 | 2021 |
| The impact of recurrent cytomegalovirus infection on long‐term survival in solid organ transplant recipients BJ Gardiner, JK Chow, SL Brilleman, AY Peleg, DR Snydman Transplant Infectious Disease 21 (6), e13189, 2019 | 18 | 2019 |
| Microbial identification using DNA target amplification and sequencing: clinical utility and impact on patient management T Basein, BJ Gardiner, GM Andujar Vazquez, AS Joel Chandranesan, ... Open forum infectious diseases 5 (11), ofy257, 2018 | 16 | 2018 |
| Surveillance bronchoscopy: is it still relevant? M Benzimra Seminars in Respiratory and Critical Care Medicine 39 (02), 219-226, 2018 | 15 | 2018 |
| Ceftazidime-avibactam (CTZ-AVI) as a treatment for hospitalized adult patients with complicated intra-abdominal infections BJ Gardiner, Y Golan Expert Review of Anti-infective Therapy 14 (5), 451-463, 2016 | 11 | 2016 |
| Hampered by historical paradigms – echinocandins and the treatment of Candida endocarditis BJ Gardiner, MA Slavin, TM Korman, RL Stuart Mycoses 57 (5), 316-319, 2014 | 11 | 2014 |
| Streptococcus pyogenes aortic aneurysm infection: forgotten but not gone BJ Gardiner, J Wong, M Yii, T Buckenham, TM Korman Infectious Disease Reports 5 (2), e11, 2013 | 11 | 2013 |
| When azoles cannot be used: the clinical effectiveness of intermittent liposomal amphotericin prophylaxis in hematology patients R Batchelor, C Thomas, BJ Gardiner, SJ Lee, S Fleming, A Wei, ... Open forum infectious diseases 8 (7), ofab113, 2021 | 10 | 2021 |
